Jf. Krowka et al., LACK OF ASSOCIATIONS OF CHEMOTACTIC CYTOKINES WITH VIRAL BURDEN, DISEASE PROGRESSION, OR LYMPHOCYTE SUBSETS IN HIV-INFECTED INDIVIDUALS, Clinical immunology and immunopathology, 85(1), 1997, pp. 21-27
Plasma samples from HIV-infected (HIV+) rapid progressors (RP) and non
progressors (NP) in the San Francisco Men's Health Study showed signif
icantly elevated levels of RANTES but not macrophage inflammatory prot
ein 1 (MIP1) alpha or MIP1 beta in comparison to HIV-seronegative (HIV
-) controls, In 32 individuals who became infected with HIV during the
course of this study, RANTES levels were significantly higher in plas
ma samples collected at the time antibodies to HIV were first detected
than in pre-seroconversion plasma samples. Both RP and NP showed sign
ificant temporal increases in plasma RANTES concentrations. No signifi
cant associations were observed, however, between plasma levels of the
se chemotactic cytokines and progression or known predictors of progre
ssion to AIDS including viral burden, levels of beta(2)-microglobulin
or neopterin, and levels of activated CD8(+) lymphocytes. These findin
gs are consistent with the results of a number of recent reports which
suggest that these chemokines do not play a major systemic role in th
e long-term control of viremia or protection against the progression o
f HIV disease. It remains possible that chemotactic cytokines may cont
ribute locally to control HIV in lymph nodes or other organs but it is
also possible that they may be mediators of potentially harmful infla
mmatory responses. (C) 1997 Academic Press.